The Castle Delivery Meeting
Nucleic Acid Therapeutics, including ASOs, siRNAs, PMOs, mRNA, have enabled development of novel therapeutic options for disease targets previously considered un-druggable by conventional small molecule and biologics means. Â While major advances and recent regulatory drug approvals have been made with liver and CNS, with ...
Evaluating Biopharma Oligonucleotides Event
This exclusive event features oligonucleotide experts who have agreed to share their unique and personal experiences, insight, and advice to help companies understand and implement proper technology strategies needed to accelerate development; production and manufacturing strategies to support scale-up and sustainability; and collaboration strategies necessary ...
